Kelly Patrick F. 4
4 · Forma Therapeutics Holdings, Inc., · Filed Jun 22, 2020
Insider Transaction Report
Form 4
Kelly Patrick F.
SVP, Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-06-18+116,890→ 0 totalExercise: $20.00Exp: 2030-06-17→ Common Stock (116,890 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the stock option shall vest on June 18, 2021 and the remainder of the shares vest in equal monthly installments for a period of 36 months thereafter.